Please rate your comfort level in initiating and monitoring hepatitis C treatment (n = 46) |
|
Not comfortable |
5 (10.9%) |
Somewhat comfortable |
7 (15.2%) |
Neutral |
13 (28.3%) |
Comfortable |
18 (39.1%) |
Very comfortable |
3 (6.5%) |
Please rate your comfort level in monitoring hepatitis C patients not on treatment (n = 41) |
|
Not comfortable |
13 (31.7%) |
Somewhat comfortable |
9 (22.0%) |
Neutral |
8 (19.5%) |
Comfortable |
9 (22.0%) |
Very comfortable |
2 (4.9%) |
Please rate your comfort level in monitoring hepatitis B patients not on treatment (n = 26) |
|
Not comfortable |
4 (15.4%) |
Somewhat comfortable |
4 (15.4%) |
Neutral |
9 (34.6%) |
Comfortable |
7 (26.9%) |
Very comfortable |
3 (7.7%) |
Please rate your comfort level in initiating and monitoring hepatitis B treatment (n = 34) |
|
Not comfortable |
7 (20.6%) |
Somewhat comfortable |
5 (14.7%) |
Neutral |
10 (29.4%) |
Comfortable |
7 (20.6%) |
Very comfortable |
5 (14.7%) |
Please rate your comfort level in providing medical therapy for HCC treatment (n = 40) |
|
Not comfortable |
14 (35.0%) |
Somewhat comfortable |
9 (22.5%) |
Neutral |
12 (30.0%) |
Comfortable |
4 (10.0%) |
Very comfortable |
1 (2.5%) |
Please rate your comfort level in monitoring HIV/HCV co-infected patients (n = 44) |
|
Not comfortable |
8 (18.2%) |
Somewhat comfortable |
4 (9.1%) |
Neutral |
5 (11.4%) |
Comfortable |
23 (52.3%) |
Very comfortable |
4 (9.1%) |
Please rate your comfort level in monitoring patients with cirrhosis (n = 35) |
|
Not comfortable |
2 (5.7%) |
Somewhat comfortable |
5 (14.3%) |
Neutral |
13 (37.1%) |
Comfortable |
13 (37.1%) |
Very comfortable |
2 (5.7%) |
Please rate your comfort level in managing patients with ESLD (n = 40) |
|
Not comfortable |
16 (40.0%) |
Somewhat comfortable |
4 (10.0%) |
Neutral |
1 (27.5%) |
Comfortable |
8 (20.0%) |
Very Comfortable |
1 (2.5%) |
Please rate your awareness of available HCV drugs (n = 47) |
|
Not aware |
4 (8.5%) |
Somewhat aware |
9 (19.2%) |
Aware |
24 (51.1%) |
Very aware |
10 (21.3%) |